| clinical trial | Q30612 |
| P3098 | ClinicalTrials.gov ID | NCT00003834 |
| P6099 | clinical trial phase | phase II clinical trial | Q42824440 |
| P17 | country | United States of America | Q30 |
| Canada | Q16 | ||
| P582 | end time | 2005-12-01 | |
| P921 | main subject | rectum adenocarcinoma | Q18554959 |
| P1050 | medical condition | adenocarcinoma | Q356033 |
| P2899 | minimum age | 18 | |
| P1132 | number of participants | 44 | |
| P4844 | research intervention | leucovorin calcium | Q27077063 |
| fluorouracil | Q238512 | ||
| calcium oxalate | Q412399 | ||
| P6153 | research site | Metro-Minnesota Community Oncology Research Consortium | Q30269543 |
| P580 | start time | 1999-03-01 | |
| P8363 | study type | interventional study | Q78089383 |
| P1476 | title | A Phase II Study of Patients With Unresectable Metastatic Adenocarcinoma of the Colon or Rectum (Per 04/99 Amendment) Old Title: A Phase II Study of Patients With Unresectable Metastatic Adenocarcinoma of the Colon or Rectum Confined to the Liver |